Bioequivalence of Mebeverine

Evaluation of Bioequivalence of Mebeverine 200 mg in Healthy Volunteers

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

IRCT

Registry ID

IRCT20221002056075N1

Enrollment

Registered

2022-10-08

Start date

2022-10-25

Completion date

Unknown

Last updated

2022-11-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

comparison of test and reference mebeverine.

Interventions

Intervention group:.

Eligibility

Sex/Gender

All

Age

18 Years to 55 Years

Inclusion criteria

Inclusion criteria: Common health of the volunteer by physician exam

Exclusion criteria

Exclusion criteria: Routine exclusion studies in this studies

Design outcomes

Primary

Measure	Time frame
Confirm or not confirm the test drug. Timepoint: half of volunteers get test and next week reference and the other half inverse. Method of measurement: by HPLC.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSima Sadrai

Tehran University of Medical Sciences

sadrai@tums.ac.ir+98 21 6695 9054

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026